Thursday, June 12, 2008

Pfizer - Chantix: just what did the FDA know, and when?


Physician and top smoking cessation researcher Dr John Spangler, director of Tobacco Intervention Programs at the Wake Forest University School of Medicine in Winston-Salem, N.C says U.S. regulators and Pfizer brushed aside his concerns a year ago about possibly dangerous side effects from longer-term use of the stop-smoking drug Chantix.

ABC News have the story.

No comments: